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Abstract
Background: To evaluate the association between maternal and paternal smoking during pregnancy, and asthma
among offspring.
Methods: We conducted a hospital-based birth retrospective observational birth cohort study in a University-based
Obstetrics and Gynecology Department, Kuopio University Hospital, Finland. 39 306 women, delivering between
1989 and 2006, were linked to the national register for asthma reimbursement for their offspring (2641 asthmatics).
Pregnancy factors were recorded during pregnancy.
Results: The risk of asthma was significantly elevated if both parents smoked (aOR 3.7; 95 % Cl 3.2-4.4) and it
remained high in only paternal smoking families (aOR 2.9; 95 % Cl 2.5-3.3) as well as only maternal smoking families
(aOR 1.7; 95 % Cl 1.2-2.2). Paternal cessation of smoking during pregnancy seemed to reduce the risk of asthma
regardless of maternal smoking (aOR 0.3-0.4).
Conclusions: Parental smoking, and especially paternal smoking, was significantly associated with the risk of
asthma in offspring and paternal cessation of smoking during pregnancy was associated with a decreased risk of
childhood asthma regardless of maternal smoking. The results indicate that both parents should be encouraged to
quit smoking during pregnancy, since it is a relatively easy and cheap way to reduce the risk of asthma in offspring.
Trial registration: The study is registered in Kuopio University Hospital register (TUTKI): ID5302448
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Background
Asthmatic diseases are among the most common
chronic diseases affecting both children and young
adults [1–3]. The prevalence of asthma among children
varies worldwide, being lowest, only 2-4 %, in Asian
countries and highest in the United Kingdom, Canada,
Australia and other developed countries, where the
prevalence might be up to 15 to 20 % [1, 2]. In Finland,
the prevalence of asthma among children varies between
7 to 9 %, but has diminished about 30 % in the past dec-
ade especially among children aged 0–4 years of age
probably because of more specific diagnostic criteria [4].
The etiology and risk factors are often categorized to
genetic, environmental and host factors, and global dif-
ferences are probably a result of gene-by-environment
interactions [2, 3].
The prenatal risk factors of asthma are multifactorial,
including maternal smoking (both active and passive),
maternal stress and exposure to various substances such
as antibiotics, dietary interventions during pregnancy,
and birth by cesarean section [3, 5, 6]. Maternal smoking
also affects fetal growth, increasing the risks of low birth
weight infants and preterm birth, which in turn are also
known to increase the risk of asthma [5, 7–9]. Both ma-
ternal prenatal smoking and postnatal exposure to envir-
onmental tobacco smoke (ETS) are associated with
elevated risks of behavioural problems, neurocognitive
deficits and sudden infant death syndrome [9, 10].
Pregnancy is known to be a critical period of develop-
mental programming, where maternal smoking might
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influence fetal immune development through activating
or silencing fetal genes, affecting lung growth and differ-
entiation, and predisposing offspring to asthma. Expos-
ure to ETS during pregnancy is also associated with the
same effects and, through genetic variation, a proportion
of the population has been shown to be especially
vulnerable to such exposure [1, 3, 11, 12].
There are only a few reports on the association be-
tween different patterns of parental smoking, especially
paternal smoking during pregnancy, and asthma among
offspring. Håberg et al. found increased risk of wheezing
in families with postnatal exposure to paternal smoking
independently of maternal smoking during pregnancy,
but not prenatally [1]. Burke et al. (2012) published a
large review article that revealed that exposure to mater-
nal smoking, in particular during prenatal or postnatal
period, was associated with significantly increased risks
of onset of asthma and wheeze in children. Data on the
effect of exposure to paternal postnatal smoking were
limited since they found only two studies with significant
results out of five studies included in meta-analysis that
revealed a significantly increased risk of incidence of
asthma before the age of 11 years [13]. Therefore, we
assessed the effects of different parental smoking pat-
terns during pregnancy in connection with the risk of
asthma in childhood.
Methods
The study was a retrospective hospital-based birth co-
hort study and the data was derived from the clinical
birth database of the Department of Obstetrics and
Gynecology, Kuopio University Hospital, and the Social
Security Institution of Finland register for asthma medi-
cation reimbursement. Data collected between January
1989 and December 2008 covered 45 030 pregnant
women and their infants. After exclusion of stillbirths
(n = 175), neonatal deaths (n = 154), infants born before
23 weeks of gestation (n = 20), children born 2007–2008
(n = 4867) and missing information (n = 487), the data
covered 39 306 women with live-born infants. In this
cohort, 2641 children had asthma medication. Parental
(maternal/paternal) smoking was evaluated as: non-
smoker, smoker (daily smoking before and during preg-
nancy) and a quitter (quit smoking before the onset of
pregnancy or before 13 + 0 GWs). Information on maternal
and paternal pre-pregnancy characteristics was based on
maternally reported data collected from self-administered
questionnaires at 20 weeks of pregnancy. Missing data were
added by midwives and nurses during interviews at visits to
prenatal maternity clinics or labor wards at Kuopio Univer-
sity Hospital. The questionnaire consisted of 75 questions
on background items such as health habits, including both
maternal and paternal smoking, previous pregnancies and
chronic diseases. Information on pregnancy complications,
pregnancy outcome and the neonatal period was added by
midwives and nurses at the time of delivery and during the
neonatal period. Informed consent for this register study
was given by childbearing women at the time of data
collection.
Information on the need of anti-asthmatic drugs dur-
ing childhood was obtained from the Drug Prescription
Register of the Social Insurance Institution between
years 1989–2008. All medication in Finland is registered
in the Drug Prescription Register. The cost of medica-
tion prescribed by physicians, and in the case of
pediatric asthma, by pediatricians, is reimbursed by 72 %
through the National Sickness Insurance Scheme. Anti-
asthmatic drugs were categorized according to ATC-
groups R06 e.g. inhaled glucocorticoids, inhaled long act-
ing beta2-agonists and antileukotrienes. In the present
study, children who were entitled to a special reimburse-
ment for anti-asthmatic drugs and purchased them at
least once after the diagnosis were considered as asth-
matics [8, 14].
The parameters of variables were tabulated and differ-
ences between asthmatics and non-asthmatics were
tested by using Chi-square and Mann–Whitney U tests
for statistical significance. Logistic regression analyses
were used to investigate the multivariate-adjusted associ-
ation between parental smoking and asthma diagnosed
among offspring. Analyses were performed using SPSS
21.0 for Windows software.
We adjusted the analyses for maternal asthma (no vs.
yes), maternal age (≤25, 26–35, ≥36 years), maternal
parity (0, 1, ≥2), pre-pregnancy BMI (<21, 21–25,
>25 kg/m2), ART (assisted reproduction technology (no
vs. yes)), marital status (not married vs. married), child’s
sex, gestational weeks at birth (<37, 37–40, ≥ 41) and
mode of delivery (vaginal vs. cesarean). Furthermore, a
child’s follow-up time was taken into account by using
the child’s age at the onset of asthma, or among healthy
children, age at the end of the study (2006). A p-value of
<0.05 was deemed to be statistically significant.
To examine whether background information (ie,
maternal age, asthma, marital status, mode of delivery,
gestational weeks at birth and gender of child) contrib-
uted to the differences in childhood asthma incidence
related to parental smoking, we estimated the contribu-
tion of each of these factors adding them separately to
logistic regression analysis.
Results
Table 1 shows the characteristics of the study popula-
tion. Among all 39 306 live-born children, 2641 (6.7 %)
had asthma medication. 70.6 % of children with asthma
were followed over 10 years (data not shown) and the
mean follow-up time was 4.2 years. All children were
over two years of age and more than 80 % of children
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had asthma by the age of seven years. Asthmatic chil-
dren were more frequently males and born to mothers
with asthma and hypertension. They were also born
more frequently to mothers with earlier infertility prob-
lems and to married couples. Children with asthma were
born at earlier gestational weeks, more often by cesarean
section and with lower birth weight and lower Apgar
scores compared with non-asthmatics.
Table 2 shows the differences in parental smoking
habits in relation to healthy and asthmatic offspring.
The proportion of cessation of maternal smoking before
or during pregnancy was similar in both groups (13.0 %),
but children with asthma significantly more often had
smoking mothers and/or fathers throughout the preg-
nancy compared with children without asthma (mothers:
14.0; fathers: 29.5 %). Pregnancy little affected paternal
smoking habits: 24.5 % of fathers continued smoking
throughout the pregnancy Asthma prevalence was high-
est among families where either the mother or father
smoked (7.8 % and 8.1 %). Isolated paternal smoking
increased the risk of asthma 2.7–fold and isolated mater-
nal smoking increased it 1.4–fold compared with the risk
associated with non-smoking parents. In our study
population maternal smoking during pregnancy was
decreased from 13.2 % to 9.6 % in a ten year period
but similar trend in the proportion of cessation was
not seen among mothers (Data not shown).
We further evaluated the significance of different parental
smoking habits during pregnancy by multivariate analysis
(Table 3). The risk of asthma was increased in all cases with
paternal smoking, regardless of maternal smoking. The risk
of asthma was highest among children when both parents
smoked (aOR 3.7, 95 % Cl 3.2-4.4) compared with children
of non-smoking parents. The risk of asthma was also
significantly increased in families when either one of the
parents smoked (mother: aOR 1.7, 95 % Cl 1.2-2.2, father:
aOR 2.9, 95 % Cl 2.5-3.3) compared with children of non-
smoking parents. Among families where the father smoked
and the mother quit during pregnancy, the risk of asthma
among children was still significantly increased (aOR
2.8, 95 % Cl 2.3-3.4). The interaction testing between
maternal and paternal smoking status were non- sig-
nificant (p = 0.727). However, a protective effect as
regards the risk of asthma among offspring was detected
in all cases when the father quit smoking in early preg-
nancy, regardless of maternal smoking (aORs 0.3-0.4)
(Table 3).
Since maternal exposure to paternal smoking might be
more direct in married families, we evaluated separately
children with married couples (Table 4). In this sub-
group analysis, no significant differences were observed.
Discussion
Our main finding was that parental smoking, and espe-
cially paternal smoking regardless of maternal smoking,
increased the risk of asthma among offspring. We fur-
ther observed that the risk was cumulative in nature,
since maternal smoking increased the risk of asthma
1.7-fold compared with non-smokers, paternal smoking
Table 1 Basic characteristics of the study population in relation
to asthma at any time among offspring
Asthma* No asthma* p-value**
n = 2641 (6.7 %) n = 36 665 (93.3 %)
Primipara 1 039 (39.3) 15 131 (41.3) 0.114
Maternal
Asthma 116 (4.4) 876 (2.4) <0.001
GDMa 143 (5.4) 2 314 (6.3) 0.066
Hypertension 76 (2.9) 725 (2.0) 0.002
Preeclampsia 115 (4.4) 1 438 (3.9) 0.217
ARTb 183 (6.9) 1736 (4.7) <0.001
Maternal age, years 28.7 (5.3) 29 (5.5) 0.313
<25 780 (29.5) 9 944 (27.1)
26-35 1 581 (59.9) 22 049 (60.1)
>35 280 (10.6) 4672 (12.7) 0.001
Mean prepregnancy
BMIc, kg/m2
23.4 (4.5) 23.2 (4.3) 0.020
Mean number of
previous pregnancies
1.5 (1.6) 1.4 (1.6) 0.08
Mean number of
previous deliveries
1.1 (1.2) 1.0 (1.3) 0.57
Marital status
not married 900 (34.1) 13 238 (36.1)
married 1 741 (65.9) 23 427 (63.9) 0.036
Mode of delivery
Vaginal 2 040 (77.2) 29 925 (81.6)
Cesarean section 601 (22.8) 6 740 (18.4) <0.001
Single 2 500 (94.7) 35 340 (96.4)
Twins 133 (5.0) 1 258 (3.4)
Triplets 8 (0.3) 67 (0.2) <0.001
Premature delivery 380 (14.4) 2 594 (7.1) <0.001
Boy 1 602 (60.7) 18 241 (50.2) <0.001
Mean gestational age, w 38.4 (3.2) 39.2 (2.1) <0.001
Apgar score 5 min <7 70 (2.7) 663 (1.8) 0.002
Chorioamnionitisd 48 (1.8) 414 (1.1) 0.002
Mean follow-up time
of children, years*
4.2 (3.6) 9.3 (5.3) <0.001
*Values are mean (±2 SD) or N (%)
** p-value obtained in univariate model
aGestational diabetes mellitus
bART (assisted reprodution technology), including IVF (in-vitro fertilization), ICSI
(intracytoplasmic sperm injection), insemination and ovulation induction by
clomiphene and other medicines
cData missing in 1984 (4.5 %) cases
dData missing in 7 (0 %) cases
Harju et al. BMC Public Health  (2016) 16:428 Page 3 of 7
increased it 2.9-fold and when both parents smoked
there was a 3.7-fold increased risk. Interestingly, paternal
smoking represented an even more significant risk of
asthma among offspring than maternal smoking. Several
reasons might explain these findings. First, because of
changes in the social acceptability of smoking and re-
ports on the possible adverse consequences of smoking,
mothers might have been more inclined to deny or
underestimate their smoking. Further, there is some
evidence that prenatal exposure might have a greater im-
pact on pediatric asthma than postnatal exposure [15].
However, the precise effect of pre- and postnatal expos-
ure to ETS on childhood asthma and other adverse out-
comes are difficult to identify, since it is likely that
women who smoke during pregnancy continue smoking
after delivery [16]. Furthermore, ETS itself is difficult to
Table 2 Parental smoking characteristics before and during pregnancy
Asthma
Total No asthma Prevalence
N (%) N (%) Asthma n (%) n/N (%) p-value aOR* 95%CI p-value**
Maternal
Non-smokersa 28743 (73.1) 26881 (73.3) 1862 (70.5) 6.5 1 <0.001
Recent quittersb 5103 (13.0) 4755 (13.0) 348 (13.2) 6.8 1.10 (1.0-1.3) 0.218
Smokers 4748 (12.1) 4379 (11.9) 369 (14.0) 7.8 0.001 1.36 (1.2-1.6) <0.001
Missing 712 (1.8) 650 (1.8) 62 (2.3) 8.7
Paternal
Non-smokersa 22394 (57.0) 20921 (57.1) 1473 (55.8) 6.6 1 <0.001
Recent quttersb 4763 (12.1) 4528 (12.3) 235 (8.9) 4.9 0.31 (0.3-0.4) <0.001
Smokers 9633 (24.5) 8853 (24.1) 780 (29.5) 8.1 <0.001 2.73 (2.4-3.1) <0.001
Missing 2516 (6.4) 2363 (6.4) 153 (5.8) 6.1
aNo smoking before or during pregnancy
bQuit smoking prior to or during pregnancy
*Adjusted for the following maternal factors at birth: asthma, age, parity, pre-pregnancy BMI, ART, and marital status, parental smoking plus gender of child,
gestational weeks at birth, mode of delivery and age at the onset of asthma, or among controls, follow-up age
**p-value for adjusted analysis obtained from the trend test (Wald) in logistic regression analysis
Table 3 Association between parental smoking during pregnancy and risk of asthma at any time among offspring
Maternal and paternal
smoking
No asthma
N = 36665
Asthma N = 2641 Asthma Prevalence (%) OR 95%CI p-value aOR*95%CI p-value**
No maternal smoking
Paternal non-smokera 18828 (51.4) 1307 (49.5) 6.5 1 1
Paternal recent quitterb 2362 (6.4) 124 (4.7) 5.0 0.76 (0.6-0.9) 0.004 0.35 (0.3-0.4) <0.001
Paternal smoking 4463 (12.2) 370 (14.0) 7.7 1.19 (1.1-1.3) 0.004 2.87 (2.5-3.3) <.0.001
Maternal recent quitterb
Paternal non-smokera 1271 (3.5) 98 (3.7) 7.2 1.11 (0.9-1.4) 0.334 1.17 (0.9-1.5) 0.182
Paternal recent quitterb 1278 (3.5) 68 (2.6) 5.1 0.77 (0.6-1.0) 0.337 0.41 (0.3-0.5) <0.001
Paternal smoking 1966 (5.4) 176 (6.7) 8.2 1.29 (1.1-1.5) 0.002 2.81 (2.3-3.4) <0.001
Maternal smoking
Paternal non-smokera 776 (2.1) 65 (2.5) 7.7 1.21 (0.9-1.6) 0.156 1.65 (1.2-2.2) 0.001
Paternal recent quitterb 883 (2.4) 43 (1.6) 4.6 0.70 (0.5-1.0) 0.026 0.30 (0.2-0.4) <0.001
Paternal smoking 2378 (6.5) 234 (8.9) 9.0 1.42 (1.2-1.6) <0.001 3.74 (3.2-4.4) <0.001
Missing data 2460 (6.7) 156 (5.9) 6.0
aNo smoking before or during pregnancy
bQuit smoking prior to or during pregnancy
*Adjusted for the following maternal factors at birth: asthma, age, parity, pre-pregnancy BMI, ART, and marital status, plus gender of child, gestational weeks at
birth, mode of delivery and age of asthma or among controls follow-up time
**p-value for adjusted analysis obtained from the trend (Wald) in logistic regression model
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measure, since smoking outdoors reduces but does not
completely protect children from ETS exposure at home
[17]. It is estimated that about 50 % of women who quit
smoking just before or during pregnancy might smoke
again after delivery [16, 18]. Therefore, excessive effect
of paternal smoking to childhood asthma might be due
to mothers who quit smoking, but continued it after
delivery and thus exposed their offspring to ETS.
Maternal cessation reduced the risk only from 3.7- to
2.8-fold, and surprisingly, paternal smoking cessation
during pregnancy showed an even more protective effect
against asthma in offspring regardless of maternal smok-
ing. One of the potential biological mechanisms of pater-
nal smoking and childhood asthma is that the mother
and the fetus were passively exposed to smoking. On the
other hand, one would assume that a true causal effect
like a programming effect from prenatal smoking expos-
ure would be higher when directly exposed through
maternal smoking, compared with being indirectly
exposed through paternal smoking. Accordingly it is well
known that smoking habit is a marker of risky healthy
behavior and therefore those who continue smoking
may represent a high risk group causing a residual con-
founding and some bias to the study setting.
Paternal cessation of smoking during pregnancy re-
duced the risk of asthma among offspring 0.4-fold. The
prevalence of asthma was low (4.6 to 5.1 %) if the father
was a recent quitter. It was intriguing how fathers who
quit smoking during pregnancy had lower risk of asthma
in the offspring compared to non-smoking fathers. It has
been shown in two earlier studies that paternal smoking
after birth is associated with an increased risk of respira-
tory diseases among offspring, but prenatal paternal
smoking was found not to have such an effect [1, 13].
However, earlier studies have not been focused on the
significance of paternal smoking or cessation during
pregnancy and the risk of asthma among offspring. Our
findings confirm the previously shown well-known in-
creased risk of asthma among offspring with maternal
prenatal smoking [1, 5, 9, 19]. However, such a findings
might have been due to the “healthy smoker” effect,
where reduced postnatal ETS might have affected the re-
sults, since the true effect of prenatal paternal smoking
might has been small [19].
Further, we found that maternal cessation of smoking
had a protective effect against asthma, as shown before
[9]. The incidence of asthma was reduced from 7.7 % to
7.2 % if the mother quit, and if both parents quit smok-
ing, asthma prevalence diminished even more-from 9.0
to 5.1 %. Reasons for smoking and cessation are multi-
factorial. Maternal smoking during pregnancy has been
associated with fear of weight gain, partners’ or friends’
smoking habits and psychiatric comorbidities. Smoking
cessation is more common in parents with higher socio-
economic status, low-level cigarette smoking before
pregnancy, awareness of the effects of smoking during
pregnancy and in parents who are more responsible
towards children and family [20, 21]. Parents, and espe-
cially fathers, who quit smoking before the childbirth
were possibly more likely to be nonsmokers after birth,
they probably shielded their offspring from secondhand
exposure to smoke and were more likely to stop
Table 4 Association between parental smoking during pregnancy and risk of asthma at any time among offspring in married families
No asthma N = 23427 Asthma N = 1741 Asthma prevalence (%) aOR*95%CI p-value**
No maternal smoking
Paternal non-smokera 14227 (60.7) 1040 (59.7) 6.8 1
Paternal recent quitterb 1228 (5.2) 64 (3.7) 5.0 0.30 (0.2-0.4) <0.001
Paternal smoking 2967 (12.7) 251 (14.4) 7.8 3.01 (2.6-3.7) <.0.001
Maternal recent quitterb
Paternal non-smokera 679 (2.9) 51 (2.9) 7.8 1.12 (0.8-1.5) 0.0483
Paternal recent quitterb 528 (2.3) 35 (2.0) 6.2 0.50 (0.3-0.7) <0.001
Paternal smoking 1008 (4.3) 87 (5.0) 7.9 2.71 (2.1-3.5) <.0.001
Maternal smoking
Paternal non-smokera 323 (1.4) 27 (1.6) 7.7 1.59 (1.0-2.5) 0.042
Paternal recent quitterb 280 (1.2) 13 (0.7) 4.4 0.22 (0.1-0.4) <0.001
Paternal smoking 966 (4.1) 101 (5.8) 9.5 3.94 (3.1-5.1) <0.001
Missing data 1221 (5.2) 72 (4.1) 5.6
aNo smoking before or during pregnancy
bQuit smoking prior to or during pregnancy
*Adjusted for the following maternal factors at birth: asthma, age, parity, pre-pregnancy BMI and ART, plus gender of child, gestational weeks at birth, mode of
delivery and age of asthma or among controls follow-up time
**p-value for adjusted analysis obtained from the trend test (Wald) in logistic regression model
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smoking when children exhibited signs of respiratory
morbidity in early life.
The prevalence of maternal smoking during pregnancy
varies between countries, but in industrialized countries
its incidence has varied between 13 and 38 % in the
latest reports [9]. Prenatal exposure to smoking is re-
ported to be less than 7 % in some Eastern countries,
but higher than 25 % in Holland, Poland and North
America [19]. In Finland, the incidence of the maternal
smoking is 16 % and has been at the same level as in the
late 1980s. In 2012, about 17 % of Finns aged 15–64
smoked daily and accounted for 21 % of men and 14 %
of women [22, 23]. Our results are comparable, varying
from 12.1 % among pregnant women to 24.5 % among
their spouses during pregnancy. Smoking during preg-
nancy is known to be more prevalent among younger
and less well-educated women and those with low in-
comes [21, 24]. Smoking mothers also more often have
unintended pregnancies and they smoke more cigarettes
before pregnancy compared with those who quit. Being
unmarried is also known to be associated with smoking
during pregnancy [16, 20, 24]. Our results are similar,
since smoking mothers were younger (more frequently
less than 25 years old) and more frequently unmarried
(data not shown).
The most significant strength of this study is the qual-
ity of the data. We gathered data from a single university
hospital with uniform collection criteria. The personal
identity code system used in Finland gave us the oppor-
tunity to link our birth register database to the register
at KELA, the Social Insurance Institution of Finland.
This institution gave us reliable data on pediatric
asthma, as evaluated similarly in two earlier Finnish
studies concerning childhood asthma [8, 14]. We also
managed to control a relatively large number of poten-
tial confounding factors known to affect asthma risk
among offspring. On the other hand, data has been pro-
duced mainly for administrative and statistical purposes
rather than for research and cannot be used to indicate
causality in the study, only the association between par-
ental smoking and asthma among offspring.
Our study has some limitations. Unfortunately we had
no precise information on the amount of cigarettes
smoked per day and therefore were not able to examine a
possible dose–response aspect of the risk of childhood
asthma. This would have been interesting, since maternal
smoking has been shown to be a dose-dependent risk fac-
tor as regards the development of asthma [25, 26]. Further,
there is not a precise definition of smoking and smoking
cessation during pregnancy in epidemiological studies. In
at least two previous studies the definition of smoking has
been at least one cigarette per day [27, 28]. Therefore, our
classification might have resulted in underestimation of
the actual number of smokers. Further, self-reported
smoking is considered to be a valid way to study tobacco
exposure during pregnancy in observational studies in
comparison with assessment of biomarkers such as cotin-
ine [29]. However, it can be argued that self-reporting may
has led to underestimation of the prevalence of smoking
[30], even though our data was based on both antenatal
self-reporting and maternity case notes.
In this study we could not use marital status as a
definite proxy for father living with pregnant spouse or
not since cohabiting couples (unmarried) are also mainly
living in same household. It is very popular and common
phenomenon in Finland living together without marriage
nowadays. However, marital status was included as con-
founders since outcome variable- childhood asthma
and parental smoking is very much related to marital
status as well- that is cohabiting parents do smoke
more often compared to married parents. An add-
itional sub-analysis did not reveal any stronger associ-
ation in married families.
Smoking is known to be a marker of lifestyle and health
behavior and is often associated with social status. Unfor-
tunately we had no information on SES and causality
cannot therefore be shown in this kind of study setting;
only conclusions about associations can be suggested, tak-
ing the known weaknesses of register-based studies into
account. We also lack information on the environmental
risk factors of asthma, such as pollution, daycare attend-
ance, socio-economic markers and neonatal respiratory
morbidity after birth. Furthermore, we chose logistic
regression analyses to investigate the multivariate-adjusted
risk of asthma among offspring. Children’s follow-up times
represented a variable that might have brought some bias
to the results and children who developed asthma at a
younger age might have had greater weight in analysis.
Conclusion
Smoking during pregnancy is associated with many
pregnancy complications such as preterm delivery, low
birth weight, placental abruption, and placental insuffi-
ciency [9, 10, 21, 31, 32]. We showed here how parental
smoking, and especially paternal smoking, has important
effects on the incidence of asthma among offspring. This
should encourage healthcare professionals to support both
parents in quitting smoking during pregnancy in order to
reduce the risk of asthma among offspring. Smoking ces-
sation during pregnancy is a relatively easy and cheap way
to reduce asthma morbidity among children.
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